Accretion Pharma Limited
Frequently asked questions
What sector does Accretion Pharma Limited belong to?
Accretion Pharma Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the P/E ratio of ACCPL?
Accretion Pharma Limited has a price-to-earnings (P/E) ratio of about 24.70. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of ACCPL?
The market capitalisation of Accretion Pharma Limited is approximately ₹239 Cr.
Is Accretion Pharma Limited profitable?
For its latest reported financial year, Accretion Pharma Limited recorded a net profit margin of about 10.79%.
Does ACCPL pay a dividend?
Accretion Pharma Limited does not currently show a dividend yield in our data.
What is the return on equity (ROE) of ACCPL?
Accretion Pharma Limited has a return on equity (ROE) of about 27.60%. ROE measures how much profit a company generates relative to shareholders' equity.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.